TrialALTO-100 in MDD and/or PTSD
Trial details
- Registry ID
- NCT05117632
- Phase
- Phase 2
ANRO
Alto Neuroscience
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
10Trials in this database
6Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity sourceALTO-300 in Depression
Trial details
- Registry ID
- NCT05118750
- Phase
- Phase 2
ALTO-300 in Depression (ALTO-300-004)
Trial details
- Registry ID
- NCT05157945
- Phase
- Phase 2
Pilot Decentralized Trial
Trial details
- Registry ID
- NCT05419869
- Phase
- Phase 2
Phase 2b Study of ALTO-100 in MDD
Trial details
- Registry ID
- NCT05712187
- Phase
- Phase 2
Study of ALTO-300 in MDD
Trial details
- Registry ID
- NCT05922878
- Phase
- Phase 2
PD, PK, and Safety of ALTO-203 in Patients With MDD
Trial details
- Registry ID
- NCT06391593
- Phase
- Phase 2
Study of ALTO-101 in Patients With Schizophrenia
Trial details
- Registry ID
- NCT06502964
- Phase
- Phase 2
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Trial details
- Registry ID
- NCT06656416
- Phase
- Phase 2
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Trial details
- Registry ID
- NCT07553637
- Phase
- Phase 2
Latest recorded trial changes
Study of ALTO-101 in Patients With Schizophrenia
NCT06502964 · Alto Neuroscience
Primary completion date
Recorded edit− Previous value
2025-10
+ Updated value
2026-02
PD, PK, and Safety of ALTO-203 in Patients With MDD
NCT06391593 · Alto Neuroscience
Participant count type
Recorded edit− Previous value
Estimated
+ Updated value
Actual
Enrollment · participant count
Recorded edit− Previous value
count: 60; type: ESTIMATED
+ Updated value
count: 69; type: ACTUAL
Completion date type
Recorded edit− Previous value
Estimated
+ Updated value
Actual
Primary completion date
Recorded edit− Previous value
2025-04
+ Updated value
2025-04-14
Recruitment status
Recorded edit− Previous value
Recruiting
+ Updated value
Completed